Recombinant antibodies are invented antibodies formed by using recombinant DNA technology. While traditional monoclonal ...

The year 2015 marked the inception of Sanyou Bio's technological journey, laying the foundation for its core technology platform. The R&D team devoted itself to the development of display vectors, ...

University of Pittsburgh, and National Institutes of Health researchers shared promising results on a groundbreaking antibody ...

The research team, studying the efficacy of a preventive antibody-based therapy, found it successfully protects monkeys from ...

Blinatumomab is a bispecific T cell engager (BiTE) antibody construct to treat adults with Philadelphia-negative (Ph-) relapsed/refractory B-precursor acute lymphoblastic leukaemia (ALL).

Sonnet BioTherapeutics has received a patent from the European Patent Office (EPO) for its fully human albumin binding (FHAB) ...

and still retain the functionality of the antibody structure. Figure 1: Schematic diagram for the construction of n-CoDeR, using in vivo-proofread gene segments. In the present investigation we ...

Extension of long-term collaboration includes construction of new customer-dedicated bioconjugation capacity in Visp (CH) and commercial antibody supply of a new ADC The extended relationship builds ...